Central regions | Technology & innovation

New tuberculosis drug with proven efficacy tested in Russia

5 Apr '17
Infectex, a Russian biomed company, has completed clinical trials for its SQ109 candidate unparalleled elsewhere in the world, as the developers say, the Skolkovo Foundation website reported. Infectex claims this is the first new proven drug for tuberculosis in the global market in four decades.

The 2b-3 phase clinical trials were conducted in seven clinical centers in Russia and took six months. A reported 140 patients reportedly completed active therapy and showed quantifiable improvements.

Prof. Sergei Borisov of the anti-tuberculosis center at the Moscow City Department of Healthcare confirmed that the SQ109 has demonstrated safety, efficacy, and good tolerance. Tests have proved that by the end of the sixth month the SQ109-testing patient group, combining the candidate with conventional therapy, showed an up to 80% bacterial generation reduction rate, compared to 61% in a conventional approach plus placebo, Prof. Borisov said.

The SQ109 is a small 1,2-ethylenediamine molecule which is said to possess three unique action mechanisms that differ from those of other antibiotics used in tuberculosis therapy.
Publish in Twitter
Write to Facebook
Google Buzz
Write to LiveJournal
Show in MM
Share MK
COMMENT ON THIS STORY
Find Related Content

Locations: Moscow

Tags: tuberculosis (6) / Infectex (2) / clinical trials (12) / Sergei Borisov (0) / SQ109 (0) /

Latest News: Central regions
27 Apr '17 | Telecoms, media | Industry, manufacturing
25 Apr '17 | Finance, business | Technology & innovation
24 Apr '17 | Materials, extraction | Technology & innovation
19 Apr '17 | Finance, business | Technology & innovation
 

Feature stories

21 Apr '17
6 Mar '17
Developing a photonic computer, a technology that...
25 Jan '17
ScreenCardio-NN, an innovative company based in...
Search (News archive - 21074)
Advertising
RB_Partners_Venture_Report2016
Advertising
GCV_Symposium
Advertising
Why Russians do not smile
Advertising
Nano & Giga Symposium
Advertising
UNN

Latest News

28 Apr '17
In 2016, VC market sentiments changed in Russia, and...
27 Apr '17
Optic Fiber Systems, a Russian company, is ready to...
26 Apr '17
RVC, Russias national fund of funds for innovation,...

Most read stories from last week

28 Apr '17
In 2016, VC market sentiments changed in Russia, and...